ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Third Annual Mario S. Verani, MD, Memorial Lecture: The future of clinical nuclear cardiology.
Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is a great honor and privilege to present the Third Annual Mario S. Verani, MD, Memorial Lecture. Mario Verani (1943-2001) will be remembered foremost for his major contributions to the field of nuclear cardiology (Figure 1). For instance, he was one of the first investigators to recognize that fixed thallium defects were often not just scar but could be reversed by coronary revascularization. This led to an extensive revision of accepted traditional concepts on the meaning of image patterns. Mario's work on risk stratification by myocardial perfusion and function imaging after acute myocardial infarction was equally pioneering. He also laid out the basic principles for the safe use of adenosine for pharmacologic stress testing. Adenosine is now the preferred procedure all over the world in millions of patients. Dr Verani was a founding member and past president (1996-1997) of the American Society of Nuclear Cardiology (ASNC). The day before he died, he received the ASNC Distinguished Service Award. Personally, I will remember Mario as a very dear friend. We spent many hours together at meetings and gatherings all over the world. I still miss his outgoing personality, his warmth, his humor, and his enthusiasm. Above all, I enjoyed his comfortable friendship. That this friendship extended itself naturally to our wives, Regina and Marjan, made it all the more special. One of the best times we had was during a cardiology meeting in Recife, in the country of his birth, Brazil. I was greatly amused and, at the same time, impressed by the admiration and respect bestowed on him by his fellow Brazilians. One evening, we were going some place in the street on foot. We could not walk down the street without Mario being stopped by one or another Brazilian cardiologist who wanted to speak and consult with him. He was clearly greatly admired and appreciated in his country. I jokingly called him "King of Recife," and the king was holding audience. We arrived rather late where we were going... . I will always cherish the memories of our times together. I am grateful that I could visit Mario at his sickbed on the day before he passed away. He was so fragile and, at the same time, so courageous. I felt sad that there was so much that we could have discussed that we did not. Life seems sometimes full of missed opportunities... .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.